Product Images Pregabalin

This is a report showing p-values in a study. The p-values are significant and are presented as p<0.0001, indicating a highly significant result. The report also includes a graph with four dosage levels of a drug versus placebo. However, the labels on the graph are not legible, making it difficult to interpret the results.*

This data potentially shows the percentage of patients who experienced improvement in pain levels after taking different doses of Pragabalin (a medication used for nerve pain) compared to a placebo. The chart displays varying doses of Pragabalin (600mg, 450mg, and 300mg) alongside a placebo with corresponding percentages of patients who experienced improvement in pain levels. The percentage of patients improved for Pragabalin 600mg and 450mg daily doses are not available, but it is visible in the chart that both doses outperformed the Pragabalin 300mg dose and placebo in terms of improvement in pain levels.*

This is a mathematical formula for estimating Ideal Body Weight (IBW) based on age and weight. It is commonly used in medicine and healthcare to determine appropriate medication dosages and nutritional requirements. The formula is specific to adults and it adjusts for gender by multiplying the result by 0.85 for female patients.*

This is a medication guide for Pregabalin Capsules containing 225mg of USP Pregabalin per capsule. This medication should be dispensed to each patient and stored at a controlled room temperature. It should be dispensed in a tight container defined by PHARMACELTEALS 90 Capsules according to USP guidelines. The medication was manufactured by Apotex Inc and relabeled by Bryant Ranch Prepack, Inc. The packaging is child-resistant, and it is important to keep it out of reach of children.*